Allgens Medical Technology Co. Ltd. A

Allgens Medical announced that independent director Su Jian has resigned from his positions as independent director of the company's third board of directors, chairman of the audit committee, member of the strategy and ESG committee, and member of the remuneration and assessment committee, due to personal reasons. After his resignation, he will no longer hold any position in the company. Su Jian's resignation will cause the number of independent directors to fall below one-third of the total board members. His resignation will take effect upon the election of a new independent director at a shareholders' meeting. Until then, Su Jian will continue to perform his duties as independent director.

Allgens Medical Technology has announced a change to a state of having no actual controller. On July 23, 83-year-old chairwoman Huang Wanlan issued a statement to the company confirming that the basis for jointly controlling the company with her daughter Cui Han and son-in-law Hu Gang no longer exists. From that point, the parties' voting rights are no longer in concert, and the voting rights actually exercisable by any single party are insufficient to materially influence shareholder meeting resolutions. Previously, Cui Han and Hu Gang had jointly submitted an interim proposal to remove Huang Wanlan from her director position and elect Hu Gang as a non-independent director. However, at the shareholder meeting on July 20, nearly 60 percent of shareholders opposed the removal, allowing Huang Wanlan to retain her director and chairwoman positions. After company founder Cui Fuzhai passed away in June 2025, the actual controller structure was adjusted to a trio of Huang Wanlan, Cui Han, and Hu Gang, who together controlled 20.48 percent of the company's voting rights. This statement marks a pause in the battle for control.